TIMP3 and acute myeloid leukemia: To investigate the association between TIMP3 DNA methylation and the clinical characteristics of AML patients, we classified the patients as unmethylated (TIMP3 DNA methylation levels < 20%) and methylated (TIMP3 methylation rate ≥ 20%).